Results 91 to 100 of about 21,804,485 (185)

Enhancing the Solubility of BCS Class IV Antibiotics to Unleash Their Potential

open access: yesApplied Sciences
Water solubility is a key physicochemical property during drug development, yet about 90% of new drug candidates exhibit low solubility. Numerous approaches have been proposed to enhance drug solubility, including physical modification and the use of ...
Agata Grzejdziak   +3 more
doaj   +1 more source

Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery

open access: yes, 2014
The biopharmaceutics classification system (BCS) and biopharmaceutics drug distribution classification system (BDDCS) are complementary classification systems that can improve, simplify, and accelerate drug discovery, development, and regulatory ...
Benet, Leslie, Larregieu, CA, Benet, LZ
core  

Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride.

open access: yes, 2005
Literature data on the properties of chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride related to the Biopharmaceutics Classification System (BCS) are reviewed.
Barends, D M   +9 more
core   +1 more source

A science based approach to topical drug classification system (TCS). [PDF]

open access: yes, 2015
The Biopharmaceutics Classification System (BCS) for oral immediate release solid drug products has been very successful; its implementation in drug industry and regulatory approval has shown significant progress. This has been the case primarily because
Yacobi, A   +4 more
core  

Is the full potential of the biopharmaceutics classification system reached?

open access: yes, 2014
In this paper we analyse how the biopharmaceutics classification system (BCS) has been used to date. A survey of the literature resulted in a compilation of 242 compounds for which BCS classes were reported.
Andersson, Sara B. E.,   +4 more
core   +1 more source

Biopharmaceutics classification system (BCS) as a framework for selective approach to bioavailability/bioequivalence (BA/BE) investigation [PDF]

open access: yes, 2006
One of fundamental investigations, that pharmaceutical industry is expected to conduct during development of pharmaceutical formulation in order to prove its efficiency and safety, is bioavailability (BA), or bioequivalence (BE) assessment. Traditional approach to this investigation entails strictly controlled, expensive and time consuming study in ...
Petronijević, Marija   +3 more
openaire  

Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) [PDF]

open access: yes, 2019
Even though the pivotal article stating the theoretical basis for a biopharmaceutics drug classification (1) was published almost 20 years ago, the extension of BCS-based biowaiver decisions to drugs belonging to BCS classes other than those showing high
Langguth, Peter   +7 more
core  

Elucidating the Critical Role of Excipients in Gastric Emptying and Oral Absorption of a Rapidly Eliminated BCS I Drug: Implications from Zidovudine Bioequivalence

open access: yesPharmaceutics
Background/Objectives: Despite the presumption of bioequivalence for BCS Class I drugs due to their high solubility and permeability, recent evidence indicates that those with rapid systemic elimination exhibit heightened vulnerability to Cmax non ...
Yan Lin   +4 more
doaj   +1 more source

FormulationBCS: A Machine Learning Platform Based on Diverse Molecular Representations for Biopharmaceutical Classification System (BCS) Class Prediction

open access: yesMolecular Pharmaceutics
The Biopharmaceutics Classification System (BCS) has facilitated biowaivers and played a significant role in enhancing drug regulation and development efficiency. However, the productivity of measuring the key discriminative properties of BCS, solubility and permeability, still requires improvement, limiting high-throughput applications of BCS, which ...
Zheng Wu   +5 more
openaire   +2 more sources

Review: Mesoporous Silica Formulation in Biopharmaceutical Classification System (BCS) Class II Drug Development

open access: yesIndonesian Journal of Pharmaceutics
About 40% of approved drugs and nearly 90% of drug candidates have low aqueous solubility which limits their bioavailability resulting in suboptimal pharmacological activity. According to the Biopharmaceutical Classification System (BCS), drugs with low solubility and high permeability are categorized as BCS Class II, where the dissolution rate becomes
Zahra Noor Silmi Hermawan Ayodduki   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy